3[3]Wong D,Cheung A,O'Rourke K,et al.Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B[J].Ann Intern Med,1993,119:312-323.
4[4]Lin S,Sheen I,Chien R,et al.Long term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection[J].Heepartology,1999,23:971-975.
5[5]Lok AS,Heathcote EJM,Hoofnagle JH.Management of hepatitis B:2000-summary of a workshop[J].Gastroenterology,2001,120:1828-1853.
6[6]Hedziyannis SJ,Vassilopoulos D.Hepatitis B eantigen-negative chronic hepatitis B[J].Hepatology,2001,34:617-624.
7[7]Hadziyannis S,Tassopoulos N,Heathcote E,et al.A double-blind,randomized,placebo-controlled study of adefovir diivoxil(ADV) for presumed precore mutant chronic hepatitis B:48 weeks results[J].J Hepatol,2001,36(suppl 1):4.
8[8]Schiff ER.Lamivudine and 24 weeks of lamivudine/iinterferon combinationtherapy for hepatitis B eantigen-positive chronic hepatitis B in interferon nonresponders[J].J Hepatol,2003,38:818-826.
9[9]Boggs W.Vaccination and anti-HIV therpy lower hepatitis B infection rates[J].J Infect Dis,2003,188:571-577.
10[10]Hadziyannis S.Adefovir dipivoxil for the treatment of hepatitis B eantigen-negative chronic hepatitis B[J].N Engl J Med,2003,348:800-807.
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
